453 related articles for article (PubMed ID: 34012068)
1. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1381-1390. PubMed ID: 34012068
[No Abstract] [Full Text] [Related]
2. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
3. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
4. Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al.
McGurk KA; Zheng SL; Henry A; Josephs K; Edwards M; de Marvao A; Whiffin N; Roberts A; Lumbers TR; O'Regan DP; Ware JS
Genet Med; 2022 Mar; 24(3):744-746. PubMed ID: 34906520
[No Abstract] [Full Text] [Related]
5. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
[No Abstract] [Full Text] [Related]
6. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
7. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
[No Abstract] [Full Text] [Related]
8. Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1582-1584. PubMed ID: 34345026
[No Abstract] [Full Text] [Related]
9. The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort.
Johnston JJ; Brennan ML; Radenbaugh B; Yoo SJ; Hernandez SM; ; Lewis KL; Katz AE; Manolio TA; Biesecker LG
Genet Med; 2022 Mar; 24(3):736-743. PubMed ID: 34906458
[TBL] [Abstract][Full Text] [Related]
10. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG).
Monaghan KG; Leach NT; Pekarek D; Prasad P; Rose NC;
Genet Med; 2020 Apr; 22(4):675-680. PubMed ID: 31911674
[No Abstract] [Full Text] [Related]
11. Copy number alterations involving 59 ACMG-recommended secondary findings genes.
Yatsenko SA; Aarabi M; Hu J; Surti U; Ortiz D; Madan-Khetarpal S; Saller DN; Bellissimo D; Rajkovic A
Clin Genet; 2020 Dec; 98(6):577-588. PubMed ID: 33009833
[TBL] [Abstract][Full Text] [Related]
12. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
[TBL] [Abstract][Full Text] [Related]
13. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK;
Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919
[No Abstract] [Full Text] [Related]
14. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
[No Abstract] [Full Text] [Related]
15. Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Best RG; Khushf G; Rabin-Havt SS; Clayton EW; Grebe TA; Hagenkord J; Topper S; Fivecoat J; Chen M; Grody WW;
Genet Med; 2022 Mar; 24(3):509-511. PubMed ID: 35253644
[No Abstract] [Full Text] [Related]
16. The rate of secondary genomic findings in the Saudi population.
Aloraini T; Alsubaie L; Alasker S; Al Muitiri A; Alswaid A; Eyiad W; Al Mutairi F; Ababneh F; Alfadhel M; Alfares A
Am J Med Genet A; 2022 Jan; 188(1):83-88. PubMed ID: 34515413
[TBL] [Abstract][Full Text] [Related]
17. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.
Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL
Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068
[TBL] [Abstract][Full Text] [Related]
18. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
David KL; Best RG; Brenman LM; Bush L; Deignan JL; Flannery D; Hoffman JD; Holm I; Miller DT; O'Leary J; Pyeritz RE;
Genet Med; 2019 Apr; 21(4):769-771. PubMed ID: 30578420
[No Abstract] [Full Text] [Related]
19. Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes.
Chetruengchai W; Shotelersuk V
J Hum Genet; 2022 Mar; 67(3):137-142. PubMed ID: 34621001
[TBL] [Abstract][Full Text] [Related]
20. Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Raca G; Astbury C; Behlmann A; De Castro MJ; Hickey SE; Karaca E; Lowther C; Riggs ER; Seifert BA; Thorland EC; Deignan JL;
Genet Med; 2023 Feb; 25(2):100316. PubMed ID: 36507974
[No Abstract] [Full Text] [Related]
[Next] [New Search]